<DOC>
	<DOC>NCT01172756</DOC>
	<brief_summary>The aim of this study is to assess whether single oral doses of Riociguat safely improve the cardiovascular function in patients with pulmonary hypertension associated with left ventricular diastolic dysfunction</brief_summary>
	<brief_title>A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction, Left</mesh_term>
	<criteria>Male and female patients with symptomatic pulmonary hypertension due to left ventricular diastolic dysfunction Types of pulmonary hypertension other than group 2.2 of Dana Point Classification</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>Left ventricular dysfunction</keyword>
</DOC>